Breast Cancer Clinical Trial

Peer Support For Young Adult Women With High Breast Cancer Risk

Summary

This trial will recruit young adult female relatives (YARs) of male or female carriers of BRCA1/2. YARs who consent to participate will be randomized to either a 3-session peer coach-led telephone counseling intervention or usual care navigation to peer support interventions provided by community organizations that support the hereditary cancer community. Study aims are to 1) Assess intervention effects on distress and decision making outcomes, including uptake of counseling for untested YARs, 2) Identify YARs most likely to engage with and benefit from the intervention, 3) Understand intervention mechanisms. Participants will complete interviews at baseline, 1, 6, and 12 months.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

There are two targets for recruitment with different eligibility criteria.

Index carriers:

Men or women aged 18 or older with BRCA mutations with or without 2nd-tier multiplex panel genetic testing. Index carriers will have received testing.

YARs:

Female 1st-, 2nd- or 3rd-degree biological relatives of index carriers aged 21-30.

Exclusion Criteria:

Must be able to speak English or Spanish and provide informed consent

Study is for people with:

Breast Cancer

Estimated Enrollment:

560

Study ID:

NCT04248257

Recruitment Status:

Recruiting

Sponsor:

Georgetown University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 6 Locations for this study

See Locations Near You

Georgetown University
Washington District of Columbia, 20007, United States More Info
Suzanne O'Neill, PhD
Contact
202-687-0869
[email protected]
Dana Farber Cancer Center
Boston Massachusetts, 02215, United States
Hackensack University Medical Center
Hackensack New Jersey, 07061, United States
Memorial Sloan Kettering Cancer Center
New York New York, 10022, United States
University of Texas Southwestern Medical Center
Dallas Texas, 75390, United States More Info
Sukh Makhnoon, PhD
Contact
214-648-3242
[email protected]
University of Washington
Seattle Washington, 98109, United States More Info
Kathy Leppig, MD
Contact
206-606-6990
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

560

Study ID:

NCT04248257

Recruitment Status:

Recruiting

Sponsor:


Georgetown University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.